Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2016 - 2021)
Anika Therapeutics (ANIK) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with $2.5 million as the latest value for Q1 2021.
- On a quarterly basis, Change in Acquisitions & Divestments fell 83.32% to $2.5 million in Q1 2021 year-over-year; TTM through Dec 2021 was $2.5 million, a 94.44% decrease, with the full-year FY2021 number at $2.5 million, down 94.44% from a year prior.
- Change in Acquisitions & Divestments was $2.5 million for Q1 2021 at Anika Therapeutics, down from $18.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $58.8 million in Q4 2019 to a low of $2.5 million in Q1 2021.
- A 5-year average of $16.6 million and a median of $11.5 million in 2018 define the central range for Change in Acquisitions & Divestments.
- Peak YoY movement for Change in Acquisitions & Divestments: skyrocketed 411.06% in 2019, then crashed 83.32% in 2021.
- Anika Therapeutics' Change in Acquisitions & Divestments stood at $10.2 million in 2017, then rose by 12.2% to $11.5 million in 2018, then surged by 411.06% to $58.8 million in 2019, then plummeted by 69.37% to $18.0 million in 2020, then crashed by 86.11% to $2.5 million in 2021.
- Per Business Quant, the three most recent readings for ANIK's Change in Acquisitions & Divestments are $2.5 million (Q1 2021), $18.0 million (Q4 2020), and $7.0 million (Q3 2020).